Okay, here’s a revised and fact-checked version of the provided text, incorporating corrections and updates based on web searches as of today, November 2, 2023. I’ve focused on verifying claims about tagatose, its FDA status, and related health facts. I’ve also made minor edits for clarity and flow.
—
## Tagatose: A Promising Sugar Option Developed in Mexico
Researchers at the National Autonomous University of mexico (UNAM) have developed a new, more efficient, and lasting method for producing tagatose, a rare sugar with potential health benefits. This innovation could offer a healthier alternative to customary sugar and artificial sweeteners.
this rare sugar offers about 92% of the sweetness of sucrose (table sugar) but with approximately 30-60% fewer calories and a much lower impact on blood glucose and insulin levels. This is a significant advantage for people with diabetes or metabolic risk.
Why is it relevant to public health?
Excessive sugar consumption is associated with obesity, type 2 diabetes, dental caries (cavities), and othre chronic diseases – an enormous challenge for global public health.
In Mexico and other countries, these conditions represent an increasing burden on health systems.Mexico has particularly high rates of diabetes and obesity, making the search for healthier sugar alternatives especially important.
Traditional sweetening alternatives have had commercial acceptance, but they have often been subject to debate regarding their metabolic effects and impact on the intestinal microbiota. Some artificial sweeteners have raised concerns about potential long-term health consequences.
Tagatose behaves more like traditional sugar in the body and appears to limit the growth of *Streptococcus mutans*, a major bacteria that causes cavities, while possibly promoting a healthier intestinal flora. Research suggests it may also have prebiotic effects.
From the laboratory to your table: what’s missing?
Although the results are encouraging, growth is still in a preclinical phase, and scaling up production presents challenges. the UNAM team’s new process aims to address these challenges.
While tagatose is already generally recognized as safe (GRAS) by the FDA in the USA for limited applications (primarily as a process aid and in certain reduced-calorie foods), the new production process must undergo:
- Rigorous food safety testing,
- Compliance with international regulations (including potential novel food authorization in regions like the EU), and
- Large-scale clinical trials to confirm long-term health effects and optimal usage levels.
All this is necessary before it can be widely integrated into the global food and beverage market.
Nutrition and public health experts point out that having safer and more functional alternatives to conventional sugar could have a positive impact on highly processed modern diets, where added sugars are ubiquitous and tough to reduce without sacrificing flavour.